Virtual cut flow, an innovative noninvasive 4D ASL MRI biomarker of EIC bypass patency

Extracranial-intracranial (EIC) bypasses are used to treat Moya-Moya syndrome and complex aneurysms. Evaluating bypass patency is vital. Current methods include intraoperative techniques like indocyanine angiography, micro-doppler probes, and postoperative non-invasive imaging. However, adjudicating the frequent discordant imaging results is done via conventional digital subtraction angiography (DSA) despite its associated risks. Our study aims to quantitatively evaluate bypass patency by introducing a novel biomarker, the virtual cut-flow index (VCFI) derived from 4D-PACK MRI imaging. We prospectively reviewed consecutive adult patients who underwent bypass surgery at our institution between January and October 2023. MR angiography was performed, employing 4D-PACK (four-dimensional pseudo-continuous arterial spin labeling (4D-pCASL)-based angiography using CENTRA-keyhole and view sharing) imaging. We measured arterial signal intensity using regions of interest (ROIs) placed on the superficial temporal artery (STA) and a branch of the middle cerebral artery (MCA) post-bypass. We modeled signal evolution using linear regression and extracted slope α coefficients and then calculated the virtual cut-flow index (VCFI) using the equation VCFI = αMCA/αSTA. We included 18 patients corresponding to 19 bypasses. The median VCI was significantly higher in patients with a patent bypass compared to those with an occluded bypass (87.33 vs. 19.87%; p < 0.05). The median αMCA coefficient was significantly higher in patients with a patent bypass compared to those with an occluded bypass (69.21 vs. 11.34; p < 0.05). The median αSTA coefficient was significantly higher in patients with a patent bypass compared to those with an occluded bypass (102.74 vs. 44.74; p < 0.05). We introduced a novel noninvasive biomarker, the virtual cut-flow index, as a new means to assess bypass patency. While DSA remains the gold standard, VCFI offers a promising avenue for quantitative evaluation, potentially enhancing postoperative monitoring and influencing surgical planning.

Authors

Institutions

Publication Details

Journal
Neurosurgical Review
Published
2025-05-26
DOI
https://doi.org/10.1007/s10143-025-03618-7
Citations
1
Primary Topic
Moyamoya disease diagnosis and treatment
Type
article
Field-Weighted Citation Impact
1.67

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Virtual cut flow, an innovative noninvasive 4D ASL MRI biomarker of EIC bypass patency

Tomas Menovsky, Rabih Aboukaïs, Nadira Delhem, Martin Bretzner et al.
1 citations
Neurosurgical Review
Moyamoya disease diagnosis and treatment
1.67
article

Virtual cut flow, an innovative noninvasive 4D ASL MRI biomarker of EIC bypass patency

Tomas Menovsky, Rabih Aboukaïs, Nadira Delhem, Martin Bretzner, X. Leclerc, Antoine Devalckeneer, Philippe Bourgeois, G. Haddad, Gregory Kuschcinski
article en
1 citations

Abstract

Extracranial-intracranial (EIC) bypasses are used to treat Moya-Moya syndrome and complex aneurysms. Evaluating bypass patency is vital. Current methods include intraoperative techniques like indocyanine angiography, micro-doppler probes, and postoperative non-invasive imaging. However, adjudicating the frequent discordant imaging results is done via conventional digital subtraction angiography (DSA) despite its associated risks. Our study aims to quantitatively evaluate bypass patency by introducing a novel biomarker, the virtual cut-flow index (VCFI) derived from 4D-PACK MRI imaging. We prospectively reviewed consecutive adult patients who underwent bypass surgery at our institution between January and October 2023. MR angiography was performed, employing 4D-PACK (four-dimensional pseudo-continuous arterial spin labeling (4D-pCASL)-based angiography using CENTRA-keyhole and view sharing) imaging. We measured arterial signal intensity using regions of interest (ROIs) placed on the superficial temporal artery (STA) and a branch of the middle cerebral artery (MCA) post-bypass. We modeled signal evolution using linear regression and extracted slope α coefficients and then calculated the virtual cut-flow index (VCFI) using the equation VCFI = αMCA/αSTA. We included 18 patients corresponding to 19 bypasses. The median VCI was significantly higher in patients with a patent bypass compared to those with an occluded bypass (87.33 vs. 19.87%; p < 0.05). The median αMCA coefficient was significantly higher in patients with a patent bypass compared to those with an occluded bypass (69.21 vs. 11.34; p < 0.05). The median αSTA coefficient was significantly higher in patients with a patent bypass compared to those with an occluded bypass (102.74 vs. 44.74; p < 0.05). We introduced a novel noninvasive biomarker, the virtual cut-flow index, as a new means to assess bypass patency. While DSA remains the gold standard, VCFI offers a promising avenue for quantitative evaluation, potentially enhancing postoperative monitoring and influencing surgical planning.

Neurosurgical ReviewVol. 48(1)
Inserm (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Hôpital Roger Salengro (FR), Antwerp University Hospital (BE), Province of Antwerp (BE), Onco Lille (FR)
Institut National de la Santé et de la Recherche Médicale, Centre hospitalier régional universitaire de Lille
Good health and well-being
Openalex Percentile: Top 17%
Moyamoya disease diagnosis and treatment
1.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.